2813-2467

Frontiers in Antibiotics

Frontiers Media SA

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 122 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact122 DOIs
2

Add abstracts to 16 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Low impact16 DOIs
3

Deposit reference lists for 5 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact5 DOIs

DOIs for this ISSN

Showing the top 5 of 122 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 A brief insight into Citrobacter species - a growing threat… (10.3389/frabi.2023.1276982)
ORCID
48.49 86
2 Probiotics beyond the farm: Benefits, costs, and considerati… (10.3389/frabi.2022.1003912)
ORCID
42.25 48
3 Defense mechanisms of Salmonella against antibiotics: a revi… (10.3389/frabi.2024.1448796)
ORCID
41.09 43
4 Gaps in the implementation of national core elements for sus… (10.3389/frabi.2022.1047565)
ORCID
39.21 36
5 Grand challenge of antibiotics resistance: A global, multidi… (10.3389/frabi.2022.984076)
Abstract ORCID
38.91 5
6 Mapping the scarcity of data on antibiotics in natural and e… (10.3389/frabi.2024.1337261)
ORCID
34.95 24
7 Antimicrobial resistance in fish and poultry: Public health… (10.3389/frabi.2022.1043302)
ORCID
33.56 21
8 Physicians’, pharmacists’, and nurses’ education of patients… (10.3389/frabi.2024.1507868)
ORCID
33.56 21
9 Extended-spectrum beta-lactamases in poultry in Africa: a sy… (10.3389/frabi.2023.1140750)
ORCID
33.06 20
10 Antimicrobial resistance interventions in the animal sector:… (10.3389/frabi.2023.1233698)
ORCID
32.53 19
11 Resistance-resistant antibacterial treatment strategies (10.3389/frabi.2023.1093156)
ORCID
31.97 18
12 Prevalence and antimicrobial resistance profile of bacterial… (10.3389/frabi.2023.1156258)
ORCID
31.97 18
13 A review of the predictors of antimicrobial use and resistan… (10.3389/frabi.2023.1209552)
ORCID
31.97 18
14 Prevalence and genetic characterization of clinically releva… (10.3389/frabi.2023.1177954)
ORCID
31.38 17
15 Editorial: Knowledge, attitude and practices of the public a… (10.3389/frabi.2024.1374463)
Abstract ORCID
30.10 3
16 Editorial: Antimicrobial resistance in food-producing enviro… (10.3389/frabi.2024.1436987)
Abstract ORCID
30.10 3
17 Point prevalence survey to assess antibiotic prescribing pat… (10.3389/frabi.2022.993271)
ORCID
29.40 14
18 An Antimicrobial Treatment Assessment of Serratia marcescens… (10.3389/frabi.2022.942721)
ORCID
27.85 12
19 Drug-resistant bacteria in the critically ill: patterns and… (10.3389/frabi.2023.1145190)
ORCID
27.85 12
20 Gold complex compounds that inhibit drug-resistant Staphyloc… (10.3389/frabi.2023.1179354)
ORCID
26.98 11
21 Acinetobacter spp. in neonatal sepsis: an urgent global thre… (10.3389/frabi.2024.1448071)
ORCID
26.98 11
22 A whole-genome assay identifies four principal gene function… (10.3389/frabi.2022.957942)
ORCID
26.03 10
23 Comparison of antibiotic resistance genes in swine manure st… (10.3389/frabi.2023.1116785)
ORCID
26.03 10
24 Repurposing inhibitors of phosphoinositide 3-kinase as adjuv… (10.3389/frabi.2023.1135485)
ORCID
26.03 10
25 Transient comparison of techniques to counter multi-drug res… (10.3389/frabi.2023.1309107)
ORCID
26.03 10
26 The presence of antibiotic-resistant bacteria at four Norweg… (10.3389/frabi.2024.1351999)
ORCID
26.03 10
27 Trends in antimicrobial susceptibility patterns of bacterial… (10.3389/frabi.2023.1149408)
ORCID
25.00 9
28 Allele distribution and phenotypic resistance to ciprofloxac… (10.3389/frabi.2023.1164016)
ORCID
25.00 9
29 Antimicrobial susceptibility testing and tentative epidemiol… (10.3389/frabi.2023.1162636)
ORCID
23.86 8
30 Farm costs and benefits of antimicrobial use reduction on br… (10.3389/frabi.2022.1011929)
ORCID
22.58 7
31 Health risk assessment of ciprofloxacin, tetracycline, and o… (10.3389/frabi.2024.1364946)
ORCID
22.58 7
32 Unguarded liabilities: Borrelia burgdorferi’s complex amino… (10.3389/frabi.2024.1395425)
ORCID
22.58 7
33 Non-antibiotic therapies for multidrug-resistant gastrointes… (10.3389/frabi.2025.1554061)
ORCID
22.58 7
34 Correction: Phage biobanks as enabling infrastructure for pr… (10.3389/frabi.2026.1804100)
Abstract References ORCID
22.58 1
35 Point prevalence survey on antibiotic use in the hospitals o… (10.3389/frabi.2022.1045081)
ORCID
21.13 6
36 Screening Amazon rainforest plant extracts for antimicrobial… (10.3389/frabi.2023.1122400)
ORCID
21.13 6
37 Digital monitoring for data-driven antimicrobial stewardship… (10.3389/frabi.2023.1214826)
ORCID
21.13 6
38 Antimicrobial resistance of clinical bacterial isolates acco… (10.3389/frabi.2023.1291046)
ORCID
21.13 6
39 Antibiogram profiles of pathogenic and commensal bacteria in… (10.3389/frabi.2024.1351725)
ORCID
21.13 6
40 Targeting synthesis of the Chromosome Replication Initiator… (10.3389/frabi.2024.1384390)
ORCID
21.13 6
41 Practices, strategies, and challenges in antibiotic treatmen… (10.3389/frabi.2024.1439688)
ORCID
21.13 6
42 Analysis of engineered T7 bacteriophages containing genetic… (10.3389/frabi.2024.1515874)
ORCID
21.13 6
43 Factors influencing the frequency, knowledge, attitudes and… (10.3389/frabi.2025.1571096)
ORCID
21.13 6
44 Standardization and evaluation of indicators for quantifying… (10.3389/frabi.2023.1176817)
ORCID
19.45 5
45 Antimicrobial resistance control activities at a tertiary ho… (10.3389/frabi.2023.1202256)
ORCID
19.45 5
46 Focusing on antimicrobial resistant infections –are we missi… (10.3389/frabi.2023.1329081)
ORCID
19.45 5
47 Mycobactin analogue interacting with siderophore efflux-pump… (10.3389/frabi.2024.1362516)
ORCID
19.45 5
48 In vitro antimicrobial susceptibility of clinical isolates f… (10.3389/frabi.2024.1375980)
ORCID
19.45 5
49 Increased usage of doxycycline for young children with Lyme… (10.3389/frabi.2024.1388039)
ORCID
19.45 5
50 A machine learning-based strategy to elucidate the identific… (10.3389/frabi.2024.1405296)
ORCID
19.45 5